ICD-10-CM Billable Code

C82.16

Follicular lymphoma grade II, intrapelvic lymph nodes

Clinical Classification Guidelines

Medical Intelligence & Overview

Follicular lymphoma is a type of non-Hodgkin lymphoma that originates in the lymphatic system, particularly within B lymphocytes. When classified as Grade II, it indicates a moderate level of abnormal cell growth. The specific location in intrapelvic lymph nodes indicates the disease's presence within lymph nodes located in the pelvis. This form of lymphoma can impact overall health and requires careful diagnosis and management to determine the most appropriate treatment options. Understanding this condition helps patients and caregivers comprehend the disease process and potential next steps in care.

Causes & Symptoms

Clinical Causes: Genetic mutations affecting B lymphocytes Infections leading to immune system stimulation, though these are not direct causes Environmental exposures such as chemicals or radiation in rare cases Age-related changes, commonly diagnosed in older adults Family history of lymphoid cancers

Key Symptoms: Swollen lymph nodes in the pelvic region, often painless Generalized fatigue and weakness Unintentional weight loss Fever and night sweats Abdominal discomfort or fullness Persistent pain in the affected area Additional enlarged lymph nodes may be present elsewhere in the body

Diagnostic & Treatment

Diagnosis Path: Diagnosing follicular lymphoma involves multiple steps to identify and understand the extent of the disease. These typically include: - Physical examination focused on swollen lymph nodes - Imaging tests such as CT scans to visualize affected areas - Biopsy of the enlarged lymph nodes, which confirms the presence of follicular lymphoma and determines the grade - Laboratory tests like blood counts and bone marrow biopsies to assess spread - Immunophenotyping and genetic testing to classify the lymphoma subtype and grade This comprehensive approach aids in confirming the diagnosis and planning appropriate management strategies.

Treatment Protocols: Treatment options for follicular lymphoma, Grade II in intrapelvic lymph nodes, depend on the stage, symptoms, and overall health of the patient. Common management strategies include: - Observation: Sometimes, if the lymphoma is slow-growing and asymptomatic, careful monitoring is preferred. - Chemotherapy: Using drugs to target and destroy cancerous cells. - Immunotherapy: Such as monoclonal antibodies that enhance the immune system's ability to fight cancer. - Targeted therapy: Medications that interfere with specific molecules involved in lymphoma growth. - Radiation therapy: For localized disease or symptom relief. - Stem cell transplantation: In certain cases, to rejuvenate the immune system after intensive treatment. Patients work closely with their healthcare team to determine the most appropriate course based on disease characteristics and personal health considerations.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C82.16 a billable ICD-10 code?
Yes, C82.16 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C82.16?
Clinical documentation must specify the nature of Follicular lymphoma grade II, intrapelvic lymph nodes and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

follicular nodes lymphoma intrapelvic lymph